NEXTPHASE RESEARCH

Live / Registered — Registered — Section 8 accepted (as of 22 Feb 2024)

What this means for you

Registered since 25 Dec 2018. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
87906826
Registration number
5637326
Mark type
Stylized text
Filed
03 May 2018
Published for opposition
09 Oct 2018
Registered
25 Dec 2018

Goods and services

  • Class 035 — Advertising and business services: Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Owner

Prosecution history

  • 22 Feb 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
  • 22 Feb 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
  • 22 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 26 Dec 2023 — TEAS SECTION 8 RECEIVED
  • 25 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 03 Jan 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 25 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
  • 09 Oct 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 09 Oct 2018 — PUBLISHED FOR OPPOSITION
  • 19 Sept 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 31 Aug 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 24 Aug 2018 — ASSIGNED TO EXAMINER
  • 14 May 2018 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 07 May 2018 — NEW APPLICATION ENTERED

View this trademark record on Marksy